— Know what they know.
Not Investment Advice

NRIX NASDAQ

Nurix Therapeutics, Inc.
1W: +9.6% 1M: +5.4% 3M: +11.1% YTD: -2.9% 1Y: +72.9% 3Y: +78.3% 5Y: -32.5%
$17.50
-0.03 (-0.17%)
 
Weekly Expected Move ±4.3%
$14 $15 $16 $17 $17
NASDAQ · Healthcare · Biotechnology · Alpha Radar Buy · Power 58 · $1.5B mcap · 87M float · 1.27% daily turnover · Short 65% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NARROW EDGE
69.2 / 100
NoneWeakNarrowWide
Primary source: Switching Costs  ·  ROIC: -16216.4%  ·  5Y Avg: -3102.0%
Cost Advantage
82
Intangibles
36
Switching Cost
100
Network Effect
50
Scale
75
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. NRIX has a Narrow competitive edge (69.2/100) — meaningful but not impregnable advantages over competitors. The primary source of advantage is Switching Costs. Negative ROIC of -16216.4% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$28
Low
$28
Avg Target
$28
High
Based on 1 analyst since Apr 8, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 17Hold: 0Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$28.00
Analysts1
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-04-09 Wells Fargo $29 $28 -1 +72.4% $16.24
2026-01-29 Stifel Nicolaus $33 $35 +2 +88.6% $18.55
2026-01-29 Wells Fargo Derek Archila $21 $29 +8 +62.3% $17.87
2026-01-29 H.C. Wainwright $31 $32 +1 +79.1% $17.87
2026-01-08 Morgan Stanley $16 $36 +20 +94.7% $18.49
2025-12-10 H.C. Wainwright Robert Burns $28 $31 +3 +58.6% $19.55
2025-12-09 BTIG $27 $30 +3 +39.7% $21.47
2025-11-24 Truist Financial Initiated $30 +74.7% $17.18
2025-10-28 H.C. Wainwright $33 $28 -5 +134.6% $11.93
2025-10-23 BTIG Initiated $27 +154.0% $10.63
2025-10-23 Wells Fargo $22 $21 -1 +100.7% $10.47
2025-10-22 RBC Capital Gregory Renza $26 $29 +3 +172.8% $10.63
2025-10-14 H.C. Wainwright $30 $33 +3 +239.5% $9.72
2025-10-13 Wells Fargo $32 $22 -10 +125.4% $9.76
2025-10-10 Stifel Nicolaus $34 $33 -1 +238.1% $9.76
2025-10-10 Oppenheimer Matthew Biegler $30 $28 -2 +157.8% $10.86
2025-10-10 Piper Sandler $35 $32 -3 +194.7% $10.86
2025-07-15 Morgan Stanley Terence Flynn $17 $16 -1 +26.1% $12.69
2025-07-10 Oppenheimer Matthew Biegler $35 $30 -5 +136.8% $12.67
2025-03-17 Leerink Partners $28 $16 -12 +14.9% $13.93
2025-02-03 Morgan Stanley Terence Flynn Initiated $17 -10.3% $18.95
2024-12-05 BMO Capital Etzer Darout Initiated $35 +74.5% $20.06
2024-10-23 UBS David Dai Initiated $35 +41.2% $24.78
2024-10-21 H.C. Wainwright Robert Burns $26 $30 +4 +19.1% $25.19
2024-10-15 Oppenheimer Matthew Biegler $27 $35 +8 +40.7% $24.87
2024-10-15 Wells Fargo Derek Archila $25 $32 +7 +27.2% $25.16
2024-10-14 Stifel Nicolaus Stephen Willey Initiated $34 +36.1% $24.98
2024-09-05 Robert W. Baird Brian Skorney $25 $26 +1 +6.4% $24.44
2024-08-14 Oppenheimer Matthew Biegler Initiated $27 +23.2% $21.92
2024-06-27 RBC Capital Gregory Renza $23 $26 +3 +25.6% $20.70
2024-06-18 H.C. Wainwright Robert Burns Initiated $26 +41.0% $18.44
2024-06-05 Piper Sandler Tyler Van Buren Initiated $35 +119.4% $15.95
2024-04-11 RBC Capital Gregory Renza Initiated $23 +46.6% $15.69
2024-04-11 Robert W. Baird Joel Beatty Initiated $25 +59.3% $15.69
2022-12-13 Leerink Partners Initiated $28 +128.4% $12.26
2022-05-31 Wells Fargo Derek Archila Initiated $25 +147.8% $10.09

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C-
May 22, 2026
DCF
1
ROE
1
ROA
1
D/E
3
P/E
1
P/B
2
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. NRIX receives an overall rating of C-. Areas of concern: DCF (1/5), ROE (1/5), ROA (1/5), P/E (1/5), P/B (2/5).
Rating Change History
DateFromTo
2026-01-30 C C-
2026-01-03 C- C

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

38 Grade D
Profitability
0
Balance Sheet
85
Earnings Quality
72
Growth
52
Value
37
Momentum
50
Safety
100
Cash Flow
30
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. NRIX scores highest in Safety (100/100) and lowest in Profitability (0/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
4.57
Safe Zone
Piotroski F-Score
4/9
Beneish M-Score
-4.69
Unlikely Manipulator
Ohlson O-Score
-4.78
Bankruptcy prob: 0.8%
Low Risk
Credit Rating
A+
Score: 75.6/100
Trend: Improving
Earnings Quality
OCF/NI: 0.88x
Accruals: -5.2%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. NRIX scores 4.57, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. NRIX scores 4/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. NRIX's score of -4.69 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. NRIX's implied 0.8% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. NRIX receives an estimated rating of A+ (score: 75.6/100), with a improving trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-6.52x
PEG
0.48x
P/S
21.13x
P/B
4.01x
P/FCF
-6.47x
P/OCF
EV/EBITDA
-4.22x
EV/Revenue
17.01x
EV/EBIT
-4.00x
EV/FCF
-4.49x
Earnings Yield
-16.80%
FCF Yield
-15.47%
Shareholder Yield
0.00%
Graham Number
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. NRIX currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.003
NI / EBT
×
Interest Burden
0.964
EBT / EBIT
×
EBIT Margin
-4.256
EBIT / Rev
×
Asset Turnover
0.106
Rev / Assets
×
Equity Multiplier
1.274
Assets / Equity
=
ROE
-55.4%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. NRIX's ROE of -55.4% is driven by Asset Turnover (0.106), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
Price/Value
Margin of Safety
Premium
Assessment
Overvalued

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1465 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$17.50
Median 1Y
$12.64
5th Pctile
$3.38
95th Pctile
$48.40
Ann. Volatility
79.1%
Analyst Target
$28.00
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Arthur T. Sands
President, Chief Executive Officer and Director
$674,584 $— $6,374,138
Gwenn M. Hansen
Chief Scientific Officer
$556,000 $770,816 $2,498,124
Hans van Houte
Chief Financial Officer
$545,833 $587,216 $2,296,503
Christine Ring Legal
Legal Officer and Chief Compliance Officer
$527,500 $587,216 $2,263,337

CEO Pay Ratio

24144:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $6,374,138
Avg Employee Cost (SGA/emp): $264
Employees: 200,000

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
200,000
+69830.1% YoY
Revenue / Employee
$420
Rev: $83,980,000
Profit / Employee
$-1,322
NI: $-264,457,000
SGA / Employee
$264
Avg labor cost proxy
R&D / Employee
$1,541
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE -30.7% -85.5% -37.1% -42.8% -48.8% -54.2% -55.8% -55.3% -48.7% -46.0% -57.1% -57.4% -65.5% -70.2% -53.2% -57.3% -57.0% -67.3% -49.6% -55.4% -55.41%
ROA -22.5% -45.1% -26.8% -31.0% -35.4% -39.2% -40.4% -40.0% -35.2% -33.3% -37.3% -37.5% -42.7% -45.8% -37.8% -40.7% -40.5% -47.8% -39.0% -43.5% -43.50%
ROIC -7.8% -8.7% -1.6% -1.8% -2.1% -2.3% -22.3% -22.3% -20.0% -19.2% 2.2% 2.2% 2.5% 2.7% 3.1% 3.4% 3.4% 3.9% -146.9% -162.2% -162.16%
ROCE -25.6% -28.4% -28.7% -33.2% -37.9% -42.2% -53.1% -53.2% -47.7% -45.8% -57.7% -58.6% -66.7% -72.1% -37.1% -40.2% -40.2% -45.7% -45.8% -50.8% -50.77%
Gross Margin -2.7% -2.0% -3.9% -3.5% -3.2% -3.4% -5.8% -2.6% -49.2% -1.6% -2.3% -2.0% -3.0% -3.4% -4.1% -2.8% -77.3% 36.7% 65.9% -12.5% -12.46%
Operating Margin -3.7% -2.8% -5.1% -4.4% -4.0% -4.3% -7.2% -3.4% -87.3% -2.2% -3.0% -2.7% -4.0% -4.3% -4.9% -3.4% -1.1% -11.6% -6.1% -14.8% -14.79%
Net Margin -3.7% -2.8% -5.1% -4.4% -4.0% -4.2% -6.9% -3.2% -79.1% -2.0% -2.8% -2.5% -3.7% -3.9% -4.4% -3.1% -98.7% -10.9% -5.8% -13.9% -13.94%
EBITDA Margin -3.6% -2.8% -5.0% -4.3% -3.9% -4.2% -7.1% -3.2% -81.1% -2.1% -3.0% -2.6% -3.8% -4.1% -4.8% -3.3% -1.0% -10.3% -5.1% -14.8% -14.79%
FCF Margin -2.4% -2.7% -3.0% -4.2% -3.8% -4.2% -4.5% -4.2% -2.6% -2.3% -1.2% -1.0% -1.7% -1.9% -3.3% -3.6% -2.6% -2.9% -3.1% -3.8% -3.79%
OCF Margin -2.2% -2.5% -2.8% -3.9% -3.5% -3.9% -4.1% -4.0% -2.5% -2.1% -1.1% -92.6% -1.5% -1.7% -3.2% -3.4% -2.4% -2.8% -3.0% -3.6% -3.63%
ROE 3Y Avg snapshot only -55.51%
ROE 5Y Avg snapshot only -52.98%
ROA 3Y Avg snapshot only -38.25%
ROIC Economic snapshot only -42.00%
Cash ROA snapshot only -37.83%
Cash ROIC snapshot only -169.46%
CROIC snapshot only -176.99%
NOPAT Margin snapshot only -3.47%
Pretax Margin snapshot only -4.10%
R&D / Revenue snapshot only 3.41%
SGA / Revenue snapshot only 77.60%
SBC / Revenue snapshot only 28.08%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio -13.72 -14.37 -10.96 -5.34 -2.93 -4.67 -3.71 -2.85 -3.49 -3.11 -2.36 -4.68 -5.95 -10.36 -8.96 -6.19 -4.30 -3.21 -6.36 -5.95 -6.523
P/S Ratio 53.42 49.18 43.16 21.03 11.71 20.39 17.30 12.22 9.01 6.74 4.42 8.38 15.77 32.50 31.78 22.88 10.09 9.39 20.02 24.49 21.130
P/B Ratio 4.21 4.92 3.75 2.11 1.32 2.34 2.20 1.68 1.81 1.52 1.70 3.38 4.90 9.15 3.29 2.45 1.69 1.49 3.12 3.26 4.006
P/FCF -21.97 -17.94 -14.26 -5.04 -3.12 -4.90 -3.88 -2.88 -3.42 -2.99 -3.79 -8.08 -9.27 -17.16 -9.53 -6.40 -3.95 -3.26 -6.38 -6.47 -6.466
P/OCF
EV/EBITDA -10.74 -11.80 -8.70 -3.31 -1.12 -3.07 -2.07 -1.18 -1.58 -1.08 -0.56 -2.79 -4.21 -8.46 -5.62 -3.19 -1.40 -0.81 -4.45 -4.22 -4.224
EV/Revenue 41.13 39.50 33.66 12.81 4.40 13.19 9.61 5.09 4.13 2.41 1.07 5.20 11.64 27.94 21.13 12.58 3.51 2.45 13.62 17.01 17.005
EV/EBIT -10.44 -11.48 -8.49 -3.23 -1.10 -2.99 -2.02 -1.15 -1.53 -1.04 -0.53 -2.67 -4.05 -8.14 -5.41 -3.08 -1.35 -0.78 -4.15 -4.00 -3.996
EV/FCF -16.92 -14.41 -11.12 -3.07 -1.17 -3.17 -2.16 -1.20 -1.57 -1.07 -0.92 -5.02 -6.84 -14.75 -6.34 -3.52 -1.37 -0.85 -4.34 -4.49 -4.490
Earnings Yield -7.3% -7.0% -9.1% -18.7% -34.1% -21.4% -27.0% -35.0% -28.7% -32.2% -42.3% -21.3% -16.8% -9.6% -11.2% -16.1% -23.3% -31.1% -15.7% -16.8% -16.80%
FCF Yield -4.6% -5.6% -7.0% -19.8% -32.1% -20.4% -25.7% -34.7% -29.2% -33.4% -26.4% -12.4% -10.8% -5.8% -10.5% -15.6% -25.3% -30.7% -15.7% -15.5% -15.47%
PEG Ratio snapshot only 0.478
Price/Tangible Book snapshot only 3.263
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 6.70 6.70 4.70 4.70 4.70 4.70 4.51 4.51 4.51 4.51 3.40 3.40 3.40 3.40 6.46 6.46 6.46 6.46 7.02 7.02 7.018
Quick Ratio 6.70 6.70 4.70 4.70 4.70 4.70 4.52 4.52 4.52 4.52 3.40 3.40 3.40 3.40 6.46 6.46 6.46 6.46 7.02 7.02 7.018
Debt/Equity 0.00 0.00 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.15 0.15 0.15 0.15 0.05 0.05 0.05 0.05 0.10 0.10 0.103
Net Debt/Equity -0.97 -0.97 -0.83 -0.83 -0.83 -0.83 -0.98 -0.98 -0.98 -0.98 -1.28 -1.28 -1.28 -1.28 -1.10 -1.10 -1.10 -1.10 -1.00 -1.00 -0.997
Debt/Assets 0.00 0.00 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.09 0.09 0.09 0.09 0.04 0.04 0.04 0.04 0.08 0.08 0.081
Debt/EBITDA -0.00 -0.00 -0.11 -0.10 -0.09 -0.08 -0.07 -0.07 -0.07 -0.08 -0.21 -0.20 -0.18 -0.16 -0.14 -0.13 -0.13 -0.11 -0.22 -0.19 -0.193
Net Debt/EBITDA 3.21 2.89 2.46 2.13 1.86 1.68 1.65 1.66 1.86 1.95 1.73 1.71 1.49 1.38 2.84 2.61 2.62 2.31 2.09 1.86 1.859
Interest Coverage
Equity Multiplier 1.37 1.37 1.39 1.39 1.39 1.39 1.37 1.37 1.37 1.37 1.77 1.77 1.77 1.77 1.27 1.27 1.27 1.27 1.28 1.28 1.277
Cash Ratio snapshot only 6.857
Cash to Debt snapshot only 10.640
FCF to Debt snapshot only -4.878
Defensive Interval snapshot only 1005.6 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.06 0.13 0.07 0.08 0.09 0.09 0.09 0.09 0.14 0.15 0.20 0.21 0.16 0.15 0.11 0.11 0.17 0.16 0.12 0.11 0.106
Inventory Turnover
Receivables Turnover 3.05 7.74 4.41 5.09 5.73 5.81 10.88 11.74 17.16 19.33 81.04 85.14 65.58 59.39 47.43 49.06 76.85 72.77 111.97 95.71 95.705
Payables Turnover 25.90 40.06 23.14 27.15 31.42 34.77 31.50 31.96 31.66 31.68 33.00 33.73 34.28 35.61 24.79 26.99 30.25 24.60 13.87 15.14 15.144
DSO 120 47 83 72 64 63 34 31 21 19 5 4 6 6 8 7 5 5 3 4 3.8 days
DIO 0 0 0 0 0 0 -1 -1 -1 -1 -1 -1 -1 -1 0 0 0 0 0 0 0.0 days
DPO 14 9 16 13 12 10 12 11 12 12 11 11 11 10 15 14 12 15 26 24 24.1 days
Cash Conversion Cycle 106 38 67 58 52 52 21 19 9 6 -8 -8 -6 -5 -7 -6 -7 -10 -23 -20 -20.3 days
Fixed Asset Turnover snapshot only 0.983
Cash Velocity snapshot only 0.121
Capital Intensity snapshot only 9.587
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 6.1% 1.8% 1.2% 69.2% 35.1% 29.8% 21.3% 57.5% 74.8% 99.3% 94.0% 2.2% -17.8% -29.1% -30.3% 41.9% 48.3% 54.0% 27.2% 27.23%
Net Income -4.4% -2.0% -1.2% -73.4% -72.4% -53.9% -31.8% -1.9% 13.2% 20.2% 18.9% -4.8% -19.0% -34.5% -44.0% -25.6% -38.3% -36.6% -41.7% -41.69%
EPS -1.0% -1.6% -87.4% -69.2% -50.4% -27.1% -9.0% 15.7% 18.8% 21.2% 20.2% 8.8% 11.1% 6.2% 5.4% 6.6% -19.6% -12.7% -7.6% -7.56%
FCF -9.2% -2.1% -5.5% -1.6% -1.1% -91.1% -23.3% -10.4% 5.5% 47.8% 52.5% 34.0% 30.8% -1.0% -1.4% -1.1% -1.3% -44.9% -34.9% -34.85%
EBITDA -4.2% -2.0% -1.1% -73.0% -73.4% -56.1% -34.7% -5.3% 9.6% 17.1% 15.8% -7.9% -22.3% -37.7% -47.3% -29.0% -34.9% -25.3% -30.0% -29.95%
Op. Income -4.2% -2.0% -1.1% -72.4% -73.2% -56.0% -35.2% -6.3% 8.5% 15.7% 14.5% -8.5% -22.3% -37.4% -46.6% -28.7% -38.0% -34.1% -36.7% -36.69%
OCF Growth snapshot only -35.77%
Asset Growth snapshot only 2.81%
Equity Growth snapshot only 2.23%
Debt Growth snapshot only 96.90%
Shares Change snapshot only 31.73%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 1.6% 92.6% 72.4% 39.7% 24.8% 22.4% 18.0% 31.7% 28.7% 29.5% 19.9% 19.85%
Revenue 5Y 82.9% 50.8% 35.4% 35.38%
EPS 3Y
EPS 5Y
Net Income 3Y
Net Income 5Y
EBITDA 3Y
EBITDA 5Y
Gross Profit 3Y
Gross Profit 5Y
Op. Income 3Y
Op. Income 5Y
FCF 3Y
FCF 5Y
OCF 3Y
OCF 5Y
Assets 3Y 1.1% -3.6% -3.6% -3.6% -3.6% 12.0% 12.0% 12.0% 12.0% 18.2% 18.2% 18.19%
Assets 5Y 72.3% 11.7% 11.7% 11.67%
Equity 3Y -11.6% -11.6% -11.6% -11.6% 15.5% 15.5% 15.5% 15.5% 21.1% 21.1% 21.05%
Book Value 3Y -21.2% -21.3% -21.4% -25.0% -4.4% -6.3% -6.2% -2.4% 0.2% -4.5% -4.51%
Dividend 3Y
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.94 0.96 0.94 0.99 0.97 0.93 0.91 0.92 0.67 0.49 0.44 0.91 0.89 0.80 0.69 0.687
Earnings Stability 1.00 1.00 0.98 0.78 0.78 0.66 0.59 0.72 0.77 0.75 0.75 0.85 0.86 0.85 0.85 0.849
Margin Stability 0.80 0.81 0.90 0.79 0.68 0.65 0.66 0.80 0.72 0.65 0.66 0.79 0.64 0.50 0.59 0.588
Rev. Growth Consistency 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 1.00 0.50 0.50 0.50 0.500
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.50 0.50 0.87 0.99 0.95 0.92 0.92 0.98 0.92 0.86 0.82 0.90 0.85 0.85 0.83 0.833
Earnings Smoothness
ROE Trend -0.36 -0.28 -0.14 -0.07 -0.25 -0.23 -0.34 -0.39 0.29 0.26 0.28 0.22 0.05 0.01 0.011
Gross Margin Trend -0.41 -0.99 -0.53 0.93 1.25 1.89 1.84 0.41 -0.04 -0.45 -0.84 0.04 0.53 1.39 0.94 0.939
FCF Margin Trend -1.83 -1.59 -1.46 0.46 1.20 2.57 3.17 1.50 1.31 -0.52 -0.94 -0.39 -0.81 -0.89 -1.48 -1.482
Sustainable Growth Rate
Internal Growth Rate
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 0.56 0.74 0.72 1.00 0.88 0.89 0.89 0.93 0.96 0.98 0.57 0.52 0.58 0.55 0.89 0.92 1.04 0.94 0.94 0.88 0.882
FCF/OCF 1.11 1.08 1.07 1.06 1.07 1.07 1.08 1.07 1.06 1.06 1.10 1.12 1.10 1.10 1.05 1.05 1.05 1.05 1.06 1.04 1.044
FCF/Net Income snapshot only 0.921
CapEx/Revenue 24.1% 19.6% 19.0% 24.1% 23.2% 26.9% 31.7% 26.5% 15.3% 12.2% 10.9% 11.1% 15.8% 17.3% 17.0% 17.5% 12.0% 13.1% 16.7% 16.1% 16.11%
CapEx/Depreciation snapshot only 0.700
Accruals Ratio -0.10 -0.12 -0.08 -0.00 -0.04 -0.04 -0.05 -0.03 -0.01 -0.01 -0.16 -0.18 -0.18 -0.21 -0.04 -0.03 0.02 -0.03 -0.02 -0.05 -0.052
Sloan Accruals snapshot only -0.029
Cash Flow Adequacy snapshot only -22.513
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio
FCF Payout Ratio
Total Payout Ratio
Div. Increase Streak
Chowder Number
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -30.3% -10.7% -12.0% -21.3% -0.9% -2.7% -3.2% -4.2% -3.8% -0.7% -0.9% -0.5% -24.5% -15.3% -27.7% -37.2% -27.2% -25.7% -14.2% -14.6% -14.63%
Total Shareholder Return -30.3% -10.7% -12.0% -21.3% -0.9% -2.7% -3.2% -4.2% -3.8% -0.7% -0.9% -0.5% -24.5% -15.3% -27.7% -37.2% -27.2% -25.7% -14.2% -14.6% -14.63%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.003
Interest Burden (EBT/EBIT) 0.99 0.99 0.99 0.99 0.99 0.99 0.98 0.97 0.95 0.94 0.93 0.92 0.92 0.91 0.91 0.90 0.90 0.93 0.96 0.96 0.964
EBIT Margin -3.94 -3.44 -3.96 -3.96 -4.02 -4.41 -4.76 -4.42 -2.71 -2.31 -2.01 -1.95 -2.87 -3.43 -3.91 -4.09 -2.61 -3.13 -3.28 -4.26 -4.256
Asset Turnover 0.06 0.13 0.07 0.08 0.09 0.09 0.09 0.09 0.14 0.15 0.20 0.21 0.16 0.15 0.11 0.11 0.17 0.16 0.12 0.11 0.106
Equity Multiplier 1.37 1.89 1.38 1.38 1.38 1.38 1.38 1.38 1.38 1.38 1.53 1.53 1.53 1.53 1.41 1.41 1.41 1.41 1.27 1.27 1.274
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $-2.03 $-2.24 $-2.63 $-3.03 $-3.44 $-3.37 $-3.34 $-3.30 $-2.90 $-2.73 $-2.63 $-2.64 $-2.65 $-2.43 $-2.47 $-2.49 $-2.47 $-2.91 $-2.78 $-2.68 $-2.68
Book Value/Share $6.63 $6.54 $7.68 $7.66 $7.62 $6.73 $5.63 $5.62 $5.60 $5.58 $3.67 $3.65 $3.21 $2.75 $6.72 $6.31 $6.28 $6.26 $5.67 $4.89 $4.37
Tangible Book/Share $6.63 $6.54 $7.68 $7.66 $7.62 $6.73 $5.63 $5.62 $5.60 $5.58 $3.67 $3.65 $3.21 $2.75 $6.72 $6.31 $6.28 $6.26 $5.67 $4.89 $4.89
Revenue/Share $0.52 $0.65 $0.67 $0.77 $0.86 $0.77 $0.72 $0.77 $1.12 $1.26 $1.41 $1.47 $1.00 $0.78 $0.70 $0.68 $1.05 $0.99 $0.88 $0.65 $0.65
FCF/Share $-1.27 $-1.79 $-2.02 $-3.21 $-3.24 $-3.21 $-3.19 $-3.27 $-2.96 $-2.84 $-1.64 $-1.53 $-1.70 $-1.47 $-2.32 $-2.41 $-2.69 $-2.87 $-2.77 $-2.47 $-2.47
OCF/Share $-1.14 $-1.67 $-1.89 $-3.02 $-3.04 $-3.00 $-2.96 $-3.07 $-2.79 $-2.68 $-1.49 $-1.36 $-1.54 $-1.33 $-2.20 $-2.29 $-2.57 $-2.74 $-2.62 $-2.36 $-2.36
Cash/Share $6.42 $6.34 $6.64 $6.62 $6.59 $5.81 $5.73 $5.72 $5.70 $5.68 $5.27 $5.24 $4.62 $3.96 $7.77 $7.30 $7.27 $7.24 $6.24 $5.39 $4.91
EBITDA/Share $-2.00 $-2.19 $-2.58 $-2.98 $-3.38 $-3.32 $-3.33 $-3.32 $-2.94 $-2.80 $-2.72 $-2.75 $-2.76 $-2.56 $-2.61 $-2.66 $-2.65 $-2.99 $-2.70 $-2.63 $-2.63
Debt/Share $0.00 $0.00 $0.29 $0.29 $0.29 $0.26 $0.22 $0.22 $0.22 $0.22 $0.56 $0.56 $0.49 $0.42 $0.36 $0.34 $0.34 $0.34 $0.59 $0.51 $0.51
Net Debt/Share $-6.42 $-6.34 $-6.34 $-6.32 $-6.30 $-5.56 $-5.51 $-5.50 $-5.48 $-5.46 $-4.71 $-4.69 $-4.12 $-3.54 $-7.41 $-6.96 $-6.93 $-6.91 $-5.65 $-4.88 $-4.88
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score 4.566
Altman Z-Prime snapshot only 9.580
Piotroski F-Score 2 4 3 4 3 3 2 3 3 4 4 4 2 1 4 4 4 6 5 4 4
Beneish M-Score 3.90 -3.31 -2.09 -2.60 -3.13 -3.95 -3.15 0.82 -2.25 -2.30 -3.74 -4.23 -4.52 -2.12 -2.17 0.98 -6.83 -6.90 -4.69 -4.693
Ohlson O-Score snapshot only -4.783
ROIC (Greenblatt) snapshot only -51.48%
Net-Net WC snapshot only $4.16
EVA snapshot only $-249238230.00
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only A+
Credit Score 89.00 89.00 74.12 56.54 47.63 58.17 54.19 49.39 49.20 49.67 44.65 44.46 49.51 76.30 76.29 73.82 60.00 53.88 76.15 75.61 75.608
Credit Grade snapshot only 5
Credit Trend snapshot only 1.787
Implied Spread (bps) snapshot only 125.000
Industry Credit Rank snapshot only 76
Sector Credit Rank snapshot only 70

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms